Orally Administered Benidipine and Manidipine Prevent Ischemia-Reperfusion Injury in the Rat Heart

Circulation Journal

Volumn 68, Issue 3, 2004, Pages 241-246

  Sakaguchi, Masanori ^a,b   Shibata, Toshihiko ^a   Hattori, Koji ^a   Hirai, Hidekazu ^a   Hosono, Mitsuharu ^a   Aoyama, Takanobu ^a   Ikuta, Takeshi ^a   Bito, Yasuyuki ^a   Suehiro, Shigefumi ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NONE   (Japan)

Author keywords

Benidipine; Ischemia reperfusion; Manidipine; Oral administration

Indexed keywords

BENIDIPINE; CALCIUM CHANNEL BLOCKING AGENT; CREATINE KINASE; DIHYDROPYRIDINE DERIVATIVE; MANIDIPINE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ASSAY; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; ISOLATED HEART; MALE; NONHUMAN; RAT; REPERFUSION INJURY;

ADMINISTRATION, ORAL; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CORONARY CIRCULATION; CREATINE KINASE; DIHYDROPYRIDINES; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; RATS; RATS, WISTAR; VASODILATOR AGENTS; VENTRICULAR FUNCTION, LEFT;

EID: 1642422857     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.68.241     Document Type: Article

References (33)

1. Lazdunski M, Frelin C, Vibne P. The sodium/hydrogen exchange system in cardiac cells: Its biochemical and pharmacological properties and its role in regulating internal concentrations of sodium and internal pH. J Mol Cell Cardiol 1985; 17: 1029-1042.
2. Mahnensmith RL, Aronson PS. The plasma membrane sodium-hydrogen exchanger and its role in physiological and pathophysiological processes. Circ Res 1985; 57: 773-788.
3. 2+ overload in ischemic-reperfused rat hearts. Circ J 2002; 66: 390-396.
4. 2+ release from sarcoplasmic reticulum of rat heart. Am J Physiol 1996; 271: H876-H881.
5. Jahangir A, Ozcan C, Holmuhamedo EL, Terzic A. Increased calcium vulnerability of senescent cardiac mitochondria: Protective role for a mitochondrial potassium channel opener. Mech Ageing Dev 2001; 122: 1073-1086.
6. Borgers M, Thone F, Van Reempts J, Verheyen F. The role of calcium in cellular dysfunction. Am J Emerg Med 1983; 1: 154-161.
7. Nayler WG, Grau A, Slade A. A protective effect of verapamil on hypoxic heart muscle. Cardiovasc Res 1976; 10: 650-662.
8. Weintraub WS, Hattori S, Agarwal JB, Bodenheimer MM, Banka VS, Helfant RH. The effects of nifedipine on myocardial blood flow and contraction during ischemia in the dog. Circulation 1982; 65: 49-53.
9. Bush LR, Li Y-P, Shlafer M, Jolly SR, Lucchesi BR. Protective effects of diltiazem during myocardial ischemia in isolated cat hearts. J Pharmacol Exp Ther 1981; 218: 653-661.
10. Kloner RA, Braunwald E. Effects of calcium antagonists on infarcting myocardium. Am J Cardiol 1987; 59: B84-B94.
11. Hoshide S, Kario K, Mitsuhashi T, Ikeda U, Shimada K. Is there any difference between intermediate-acting and long-acting calcium antagonists in diurnal blood pressure and autonomic nervous activity in hypertensive coronary artery disease patients? Hypertens Res 2000; 23: 7-14.
12. Scholz H. Pharmacological aspects of calcium channel blockers. Cardiovasc Drugs Ther 1997; 10(Suppl 3): 869-872.
13. Yamamoto F, Manning AS, Braimbridge MV, Hearse DJ. Nifedipine and cardioplegia: Rat heart studies with the St Thomas' cardioplegic solution. Cardiovasc Res 1983; 17: 719-727.
14. Yamamoto F, Manning AS, Braimbridge MV, Hearse DJ. Cardioplegia and slow calcium-channel blockers: Studies with verapamil. J Thorac Cardiovasc Surg 1983; 86: 252-261.
15. Yamamoto F, Manning AS, Braimbridge MV, Hearse DJ. Calcium antagonista and myocardial protection: Diltiazem during cardioplegic arrest. Thorac Cardiovasc Surg 1983; 31: 369-373.
16. Fujimura Y, Tsuboi H, Esato K. Efficacy of benidipine hydrochloride on myocardial ischemia and reperfusion. J Surg Res 1995; 59: 321-325.
17. Yao K, Karasawa A. Protective effects of benidipine against myocardial damage following ischemia and reperfusion in the isolated perfused rat heart. Biol Pharm Bull 1994; 17: 517-521.
18. Paul T, Hoff BA, Tamura Y, Benedict RL. Cardioprotective effects of amlodipine in the ischemic-reperfused heart. Am J Cardiol 1989; 64: 101-161.
19. Miyabayashi T, Yamashita K, Aoki I, Motohashi M, Yashiki T, Yatani K. Determination of manidipine and its pyridine metabolite in human serum by high-performance liquid chromatography with ultraviolet detection and column switching. J Chromatogr 1989; 494: 209-217.
20. Kobayashi H, Okumura S, Kobayashi S, Kubo K, Hirata T. The antihypertensive effect and pharmacokinetics after administration of benidipine hydrochloride in rats. The Clinical Report 1991; 25: 3895-3904.
21. Karasawa A, Ikeda J, Yamada K, Kubo K, Oka T, Nakamizo N. Antihypertensive effects of the new calcium antagonist benidipine hydrochloride in conscious, renal-hypertensive dogs. Arzneimittelforschung 1988; 38: 1695-1697.
22. Wellstein A, Palm D, Belz GG, Pitschner HF. Receptor binding characteristics and pharmacokinetic properties as a tool for the prediction of clinical effects of beta-blockers. Arzneimittelforschung 1985; 35: 2-6.
23. Chester DW, Herbette LG, Mason RP, Joslyn AF, Triggle DJ, Koppel DE. Diffusion of dihydropyridine calcium channel antagonists in cardiac sarcolemmal lipid multibilayers. Biophys J 1987; 52: 1021-1030.
24. Herbette LG, Rhodes DG, Mason RP. New approaches to drug design and delivery based on drug-membrane interactions. Drug Des Deliv 1991; 7: 75-118.
25. Watanabe H, Nishio M, Miura M, Iijima T. L-type Ca channel block by highly hydrophilic dihydropyridines in single ventricular cells of guinea-pig hearts. J Mol Cell Cardiol 1995; 27: 1271-1279.
26. Yoshida K, Mitani M, Tukamoto T, Inashiro I, Shiraishi S, Yagi K, et al. Disposition of manidipine hydrochloride (CV-4093 2HCl), a new calcium antagonist, in rats and dog. Pharmacol Ther 1989; 17: 2083-2117.
27. Suzuki S, Morimoto I. Pharmacokinetic study of manidipine hydrochloride, a Ca-antagonist, in patients with essential hypertension after repeated doses. Clin Rep 1989; 23: 5043-5054.
28. Kitakaze M, Node K, Minamino T, Asanuma H, Kuzuya T, Hori M. A Ca channel blocker, benidipine, increases coronary blood flow and attenuates the severity of myocardial ischemia via NO-dependent mechanisms in dog. J Am Coll Cardiol 1999; 33: 242-249.
29. Inuo K, Niwano S, Morohoshi Y, Nakayama S, Ikeda K, Kojima J, et al. Cardioprotective effect of mexiletine in acute myocardial ischemia? Studies in the rabbit closed chest ischemia model. Circ J 2002; 66: 403-410.
30. Dairaku Y, Miura T, Harada N, Kimura M, Okumura T, Iwamoto H, et al. Effect of ischemia preconditioning and mitochondrial KATP channel openers on chronic left ventricular remodeling in the ischemic-reperfused rat heart. Circ J 2002; 66: 411-415.
31. Reimer KA, Hill ML, Jennings RB. Prolonged depletion of ATP and of the adenine nucleotide pool due to delayed resynthesis of adenine nucleotides following reversible myocardial ischemia injury in dogs. J Mol Cell Cardiol 1981; 13: 229-239.
32. Adachi T, Miura T, Suzuki K, Iimura O. Effects of verapamil on myocardial stunning in xanthine-oxidase deficient hearts: Pre-treatment versus post-ischemic treatment. Basic Res Cardiol 1994; 89: 16-28.
33. 14C-benidipine hydrochloride after repeated administration to rats. Arzneiminelforschung 1988; 38: 1747-1749.